GREENWOOD VILLAGE, Colo. & LOS ANGELES–(BUSINESS WIRE)– #UCLA–ANANDA Scientific Inc., a research focused bio-pharmaceutical company, and the Semel Institute for Neuroscience at Geffen School of Medicine UCLA today announced the commencement of a clinical trial evaluating Nantheia™ ATL5, an investigational drug combining cannabidiol (CBD) with ANANDA’s proprietary delivery technology, to evaluate the efficacy of cannabidiol for smoking cessation. (Clinical Trials.gov Identifier:NCT06218056) This tria
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
